EDGAR Filing Documents for 0001193125-20-310641

Form 8-K - Current report:

SEC Accession No. 0001193125-20-310641

Filing Date

2020-12-04

Accepted

2020-12-04 16:18:53

Documents

Period of Report

2020-12-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d39466d8k.htm	8-K	40003
2	EX-3.1	d39466dex31.htm	EX-3.1	79070
3	EX-3.2	d39466dex32.htm	EX-3.2	11958
4	EX-3.3	d39466dex33.htm	EX-3.3	11696
5	EX-4.2	d39466dex42.htm	EX-4.2	94965
6	EX-10.1	d39466dex101.htm	EX-10.1	208066
7	EX-99.1	d39466dex991.htm	EX-99.1	8016
8	GRAPHIC	g39466g1204093452940.jpg	GRAPHIC	2695
	Complete submission text file	0001193125-20-310641.txt		458947

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121

Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300

Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)